Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approval
Pharma
Vera’s dual-target atacicept wins FDA approval for IgAN
While atacicept is the first BAFF/APRIL dual inhibitor to enter the U.S. market, Vertex's povetacicept is trailing closely.
Angus Liu
Jul 7, 2026 12:23pm
Europe's CHMP reverses endorsement of Amgen's Tavneos
Jun 26, 2026 11:07am
Partner's Bizengri passes muster in FDA national priority pilot
May 11, 2026 11:08am
Regeneron ushers in new era with inaugural gene therapy approval
Apr 23, 2026 3:22pm
Novo scores FDA nod for Wegovy HD, plans April launch
Mar 19, 2026 2:11pm
Pfizer snaps up rights to commercialize diabetes GLP-1 in China
Feb 24, 2026 11:15am
